Baclofen for stroke patients with hiccups: a randomized controlled trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004554

Enrollment

Unknown

Registered

2014-01-14

Start date

2014-05-05

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hiccup

Interventions

Treatment:Baclofen

Control group:Placebo

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: We included participants aged 18-75 years with persistent or intractable hiccups resulting from stroke. In addition, no baclofen was taken within the last 15 days prior to study entry; and informed consent document has been signed.

Exclusion criteria

Exclusion criteria: Exclusion criteria included: hiccups mainly associated with cancer or other unclear mechanisms; Rejection of baclofen therapy; and failed to accept the completion of clinical treatment.

Design outcomes

Primary

Measure	Time frame
Curative rate;	—

Secondary

Measure	Time frame
Total efficacy rate;	—

Contacts

Public ContactZhang Shuangyan

Fourth affiliated Hospital of Harbin Medical University

zhangshuangyan2014@163.com+86 0451-82125948

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026